Copy
See below for a daily digest of the latest Huntington's Disease news!

People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows

Jul 13, 2017 12:07 pm | Joana Fernandes, PhD

 

Shifting chorea therapiesHuntington’s patients who are taking Xenazine for the twitching condition known as chorea can switch without concern to the newly approved Austedo, according to Austedo’s maker, Teva Pharmaceutical Industries. A Phase 3 clinical trial showed that the switch was safe and that Austedo (deutetrabenazine) did a better job of controlling chorea than Lundberg Pharmaceuticals‘ Xenazine (tetrabenazine), Teva said. Teva […]

The post People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows appeared first on Huntington's Disease News.

Read More
share on Twitter Like People with Chorea Can Switch from Xenazine To Austedo Safely, Phase 3 Clinical Trial Shows on Facebook

Metabolic Changes in Certain Brain Regions May Be Associated with Huntington’s Motor Symptoms

Jul 11, 2017 04:17 pm | Alice Melão

 

brain metabolic changes in Huntington'sA sluggish metabolism in the cells of the striatum, a brain region essential for motor function control, is associated with disease severity in Huntington’s patients, while a higher metabolism in other brain regions seems to be associated with more severe motor symptoms in patients, according to researchers. These findings resulted from a study titled “Association […]

The post Metabolic Changes in Certain Brain Regions May Be Associated with Huntington’s Motor Symptoms appeared first on Huntington's Disease News.

Read More
share on Twitter Like Metabolic Changes in Certain Brain Regions May Be Associated with Huntington’s Motor Symptoms on Facebook

Recent Posts

MSH3 Gene Mutations May Be Involved in Huntington’s Disease Progression, Study Finds
Mitoconix Bio Obtains $20 Million To Continue Developing Huntington’s Therapy MTC-1203
Ionis Completes Patient Enrollment in Phase 1/2a Trial of Ionis-HTTRx for Huntington’s Disease
Researchers Identify Variant in MSH3 Gene Related to Huntington’s Progression
Inhibiting Enzyme Slows Huntington’s Progression in Mice and Lengthens Their Lives, Study Reports

Copyright © 2017 BioNews Services, LLC, All rights reserved.
Email Marketing Powered by Mailchimp
unsubscribe from this list | update subscription preferences